Liman B. Qiu
The United Innovation Of Mengchao Hepatobiliary Technology Key Laboratory Of Fujian Province
Fuzhou, China
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Tumor immune microenvironment states inferred from TLS-associated immune-cell composition stratify prognosis in hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: February 26, 2026
Sequential personalized neoantigen vaccination following first-line treatments demonstrates safety and efficacy in advanced hepatocellular carcinoma.
Journal: International journal of cancer
Published: December 08, 2025
Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunity.
Journal: EMBO molecular medicine
Published: September 28, 2025
The effect of high lateral position on antibiotic exposure duration in patients with severe traumatic brain injury: a retrospective observational cohort study.
Journal: Frontiers in medicine
Published: July 14, 2025
Association between acetaminophen use and 30-day mortality in critically ill patients with pulmonary embolism: a retrospective cohort study using the MIMIC-IV database.
Journal: Frontiers in pharmacology
Published: July 10, 2025
Spleen-targeted neoantigen mRNA vaccine induces ISG15+ CD8+ T cell-mediated tertiary lymphoid structure formation in hepatocellular carcinoma.
Journal: Cell reports. Medicine
Published: May 06, 2025
Des-γ-carboxy Prothrombin in hepatocellular carcinoma post-operative recurrence risk evaluation.
Journal: Communications medicine
Published: June 26, 2024
TLR3 activation enhances abscopal effect of radiotherapy in HCC by promoting tumor ferroptosis.
Journal: EMBO molecular medicine
Published: October 28, 2023
Personalized neoantigen vaccine enhances the therapeutic efficacy of bevacizumab and anti-PD-1 antibody in advanced non-small cell lung cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: October 20, 2023
Identification of tumor mutations in plasma based on mutation variant frequency change (MVFC).
Journal: Molecular oncology
Published: December 07, 2022
A retrospective controlled study of TACE-HAIC-targeted-immune quadruple therapy for intermediate and advanced-stage hepatocellular carcinoma
Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: October 27, 2022
Personalized neoantigen vaccine combined with PD-1 blockade increases CD8+ tissue-resident memory T-cell infiltration in preclinical hepatocellular carcinoma models.
Journal: Journal for immunotherapy of cancer
Published: August 30, 2022
Last Updated: 09/26/2026